Camillo Golgi Prize
The Camillo Golgi Prize recognises outstanding contributions in the field of histopathology, pathogenesis, prevention and treatment of the complications and comorbidities of diabetes mellitus.
To be eligible for nomination:
- Candidates must be an EASD member
- Candidates can be from any country
- There are no age restrictions
The awardee will receive a monetary prize generously sponsored by Novo Nordisk and will deliver a Lecture during the EASD Annual Meeting in the year of the award describing the awardee’s most important scientific achievements.
Learn more about the 2024 Camillo Golgi Prize awardee:
Rodica Pop-Busui, USA
Lecture: It’s complicated: using lessons from the past and the knowledge of the present to build a future free of diabetes complications
EASD TV interview with Rodica Pop-Busui
Camillo Golgi Awardees:
2024 Madrid
R. Pop-Busui (US): It’s complicated: using lessons from the past and the knowledge of the present to build a future free of diabetes complications
2023 Hamburg
S. Herzig (DE): Diabetes complications: from classical to emerging
2022 Stockholm
M. Horowitz (AU): Gastric emptying in diabetes - backwards and forwards: a perspective from the antipodes
2021 Virtual Meeting
H.L. Heerspink (NL): Personalising the treatment for patients with type 2 diabetes: the mean is meaningless
2020 Virtual Meeting
N. Sattar (UK): Cardiovascular risks in diabetes: new insights from simple observations
2019 Barcelona
R.A. Malik (QA): Diabetic neuropathy: a time to challenge the dogma
2018 Berlin
P.P. Nawroth (DE): Diabetic complications: an alternative view on diabetes
2017 Lisbon
B.M. Frier (UK): Recurrent hypoglycaemia in diabetes: the long-term complications
2016 Munich
P. Rossing (DK): Personalising prevention of diabetic nephropathy, from proteinuria to profile-omics
2015 Stockholm
H.-P. Hammes (DE): The eye in diabetes: a personal account
2014 Vienna
S. Tesfaye (UK): Diabetic neuropathy: a journey with tears, passion, new insights and paradigm shift
2013 Barcelona
T. Lauritzen (DK): A journey from insulin absorption to screening for type 2 diabetes
2012 Berlin
G. Pugliese (IT): Galectin-3: only a stooge of RAGE?
2011 Lisbon
A. Bierhaus (DE): Failure of glucose lowering in clinical trials: the way to novel biochemical concepts explaining diabetic late complications
2010 Stockholm
D. Ziegler (DE): Diabetic neuropathy: the winding road from early detection to timely protection
2009 Vienna
P.-H. Groop (FI): Diabetic nephropathy - means, motive and opportunity
2008 Rome
A. Avogaro (IT): From damage to progenitors: the harsh days of endothelium in diabetes
2007 Amsterdam
P. Fioretto (IT): The kidney in diabetes: Dynamic pathways of injury and repair
2006 Copenhagen
M. Laakso (FI): Pathogenesis of cardiovascular disease in type 2 diabetes: Role of insulin resistance and hyperglycaemia
2005 Athens
C. Stehouwer (NL): The many faces of cvascular dysfunction in diabetes
2004 Munich
A. Ceriello (IT): Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes and cardiovascular disease? The "common soil" hypothesis revisited
2003 Paris
A. Boulton (UK): The diabetic foot: From art to science
2002 Budapest
J. Tuomiletho (FI): Prediction and prevention of type 2 diabetes - epidode 2
2001 Glasgow
A. Flyvbjerg (DK): Potential therapeutic strategies in diabetic kidney disease
2000 Jerusalem
U. Di Mario (IT): From hyperglycaemia to the dysregulation of vascular remodelling in diabetes
1999 Brussels
E. Standl (DE): The diabetic "Sweet" heart: From ailing to failing
1998 Barcelona
D.R. Tomlinson (UK): A common aetiology for diabetes complications
1997 Helsinki
H.-H. Parving (DK): Renoprotection in diabetes: Genetic and non-genetic risk factors and treatment
1996 Vienna
M.-R. Taskinen (FI): New insights into pathophysiology of dyslipidaemia in NIDDM
1995 Stockholm
R. Landgraf (DE): The impact of pancreatic grafting on secondary complications and quality of life
1994 Düsseldorf
J.E. Tooke (UK): Microvascular function in diabetes mellitus
1993 Istanbul
K.F. Hansen (NO): Blood glucose control - does it always matter? Research from glycosylated haemoglobin to renal morphology
1992 Prague
E. Kohner (UK): Blood flow changes in diabetes: What do they mean?
1991 Dublin
R. Osterby (DK): Renal Microstructures related to renal function in diabetes
1990 Copenhagen
P.J. Watkins (UK): Clinical observations and experiments in diabetic nephropathy
1989 Lisbon
G.B. Bolli (IT): From physiology of counter-regulation to prevention of hypoglycaemia in insulin-dependent diabetes mellitus
1988 Paris
C.E. Morgensen (DK): Hyper-filtration, hypertension and diabetic nephropathy
1987 Leipzig
D.J. Ewing (UK): New horizons for diabetic autonomic neuropathy
1986 Rome
G.C. Viberti (UK): Preventive strategies in diabetic kidney disease